LEADER 01127nam  2200361Ka 450 
001 9910698556403321
005 20080819162731.0
035   $a(CKB)3360000000454102
035   $a(OCoLC)244111849
035   $a(EXLCZ)993360000000454102
100   $a20080819d2004      ua             0
101 0 $aeng
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aAccess to investigational drugs$b[electronic resource] $equestions and answers
210  1$a[Bethesda, Md.] :$cNational Cancer Institute,$d[2004]
215   $a6 pages $cdigital, PDF file
225 1 $aFact sheet ;$v7.46
300   $aTitle from title screen (viewed on Aug. 19, 2008).
300   $a"11/19/04."
517   $aAccess to Investigational Drugs
606   $aHealth services accessibility
606   $aClinical trials
615  0$aHealth services accessibility.
615  0$aClinical trials.
712 02$aNational Cancer Institute (U.S.)
801  0$bGPO
801  1$bGPO
906   $aBOOK
912   $a9910698556403321
996   $aAccess to investigational drugs$93548291
997   $aUNINA